[Impairment of cardiac autonomic nervous system and incidence of arrhythmias in severe hyperglycemia].
OBJECTIVE
Deterioration of cardiac autonomic nervous system in diabetics is associated with increased cardiac and arrhythmogenic mortality. Therefore, the present study engaged in the question how heart rate variability is acutely changed in diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome. Moreover was evaluated how blood pressure, heart rate and incidence of arrhythmias can be explained by figures of heart rate variability.


METHODS
In a prospective observation of time course we investigated in 4 years consecutively 12 intensive care patients with DKA and 2 with HHS (10 male, 4 female, 19-62 years, initial plasma glucose 404-1192 mg/dl). All patients received a standardized treatment to international current guidelines. In addition to hemodynamic and clinical-chemical monitoring HRV analysis was performed continuously for at least 48 hours. Simultaneously, we determined supraventricular and ventricular arrhythmic episodes.


RESULTS
HRV was diminished over the whole spectrum in dependence on blood glucose concentration. Thus, sympathovagal balance (LF/HF ratio) was initially sympathetic predominated in blood glucose levels < 600 mg/dl (relatively prevailing LF power) and vagal predominated in blood glucose levels > 600 mg/dl (relatively prevailing HF power). In correlation analysis of HRV parameters with blood glucose rS-coefficients from -0.934 to -0.821 were achieved (p < 0.001). Further, the initial mean blood pressure correlated with the LF/HF ratio in HRV minimum (rS = 0.711, p = 0.004). The initial heart rate in relation to assumed intrinsic frequency correlated with minimal found Total Power (rS = -0.656, p = 0.011). In the period of whole 48 hours, more arrhythmic events occurred in consequence to initial glucose levels (rS = 0.693, p = 0.006). But the maximum of arrhythmic episodes was usually later ascertained than the minimum of HRV (p < 0.001). At the time of each arrhythmic maximum the sympathovagal balance (LF/HF) showed no uniform figures. Only similar in all cases was that the LF/HF ratio was found either > 4 or < 1.


CONCLUSIONS
Clinical complications in high glucose levels must be seen in the context of a nearly complete blockade of sympathetic and parasympathetic activity. Basically to extreme autonomic restriction, sympathetic and vagal predominance can change rapidly into each other. This retarded vulnerable predisposition may declare the arrhythmic potential. An important progress in the monitoring of patients could be achieved by implementation of a continuous HRV measurement because hereby the actual risk potential can be ascertained timely and reliably.
Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.
Sven
S
Süfke
Hasib
H
Djonlagić
Thomas
T
Kibbel
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000503:physiopathology*; D001341:Autonomic Nervous System / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism; D003422:Critical Care; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D016883:Diabetic Ketoacidosis / Q000503:physiopathology; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000294:innervation*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014630:Vagus Nerve / Q000503:physiopathology; D055815:Young Adult
D001786:Blood Glucose
BMJ. 2002 Dec 7;325(7376):1346-7
12468487
JAMA. 2003 Oct 15;290(15):2041-7
14559958
Diabet Med. 1999 Aug;16(8):626-31
10477206
Diabetes Care. 2006 Dec;29(12):2739-48
17130218
Am J Physiol. 1993 Jul;265(1 Pt 2):H219-25
8342636
Annu Rev Med. 1999;50:249-61
10073276
Circulation. 1996 Dec 1;94(11):2850-5
8941112
Eur Heart J. 2005 Jul;26(13):1255-61
15821004
Int J Epidemiol. 2010 Feb;39(1):223-4
19864345
Am J Physiol. 1976 Jun;230(6):1469-73
59552
Diabetes Care. 2005 Mar;28(3):668-74
15735206
Am Heart J. 1996 Nov;132(5):1086-9
8892799
Acad Emerg Med. 2002 Jul;9(7):661-70
12093705
Diabetologia. 1995 Nov;38(11):1345-52
8582545
J Hypertens. 2009 Jan;27(1):118-31
19050452
Metabolism. 1999 Jun;48(6):755-62
10381151
Ann N Y Acad Sci. 2006 Nov;1084:411-31
17151319
Diabetes. 2002 Apr;51(4):1076-82
11916928
Diabetes Care. 2006 Mar;29(3):571-4
16505508
Am Heart J. 2004 Sep;148(3):399-404
15389225
Diabetologia. 2000 May;43(5):561-70
10855530
Exp Physiol. 2001 Sep;86(5):539-41
11571479
Lancet. 2000 Mar 4;355(9206):773-8
10711923
Eur Heart J. 2001 Aug;22(16):1374-450
11482917
Circulation. 1996 Mar 1;93(5):1043-65
8598068
Diabetologia. 2000 Dec;43(12):1455-69
11151754
Diabet Med. 2008 Aug;25(8):1006; author reply 1007-8
18959618
Am J Cardiol. 2000 Aug 1;86(3):309-12
10922439
Acad Emerg Med. 2006 Feb;13(2):174-80
16436794
J Clin Endocrinol Metab. 2001 Jun;86(6):2769-74
11397885
Am J Cardiol. 2006 Aug 15;98(4):557-64
16893717
J Appl Physiol (1985). 2004 Jun;96(6):2231-9
14742450
Lancet. 1999 Aug 21;354(9179):617-21
10466661
Diabetes Care. 2001 Nov;24(11):2016-7
11679491
J Surg Res. 1996 Jun;63(1):11-6
8661164
Pacing Clin Electrophysiol. 2006 Jan;29(1):9-14
16441711
Arch Mal Coeur Vaiss. 1997 Nov;90(11):1477-84
9539821
Am J Physiol. 1997 Dec;273(6):H2876-83
9435627
Pacing Clin Electrophysiol. 1999 May;22(5):743-9
10353133
Int J Cardiol. 1998 Oct 30;66(3):275-83
9874080
Exp Physiol. 2001 Jan;86(1):1-12
11429613
Clin Neurophysiol. 2005 Jun;116(6):1273-9
15978489
Biochim Biophys Acta. 2000 Dec 15;1535(1):10-20
11113627
Diabetes Care. 2001 Jan;24(1):131-53
11194218
Circulation. 2004 Feb 3;109(4):551-6
14757684
Diabetologia. 2003 Mar;46 Suppl 1:M17-21
12652354
Diabetes Care. 2003 May;26(5):1553-79
12716821
Crit Care Med. 2003 Feb;31(2):359-66
12576937
J Clin Invest. 1993 Jul;92(1):147-54
8325979
Nephrol Dial Transplant. 2001 Mar;16(3):566-73
11239033
Int J Cardiol. 2001 Dec;81(2-3):243-9
11744142
Cardiol Rev. 2005 Sep-Oct;13(5):223-30
16106183
Diabetes. 2002 Dec;51(12):3524-31
12453910
Arch Intern Med. 1994 Nov 14;154(21):2473-9
7979844
Cardiovasc Res. 2000 Jan 1;45(1):173-6
10728332
J Am Coll Cardiol. 1994 Nov 15;24(6):1515-22
7930284
Diabetologia. 2010 Oct;53(10):2120-8
20549180
Diabetes Care. 2003 Oct;26(10):2959-60
14514613
Diabetes Care. 2000 Dec;23(12):1862-4
11128375
Int Heart J. 2009 Sep;50(5):627-41
19809211
Diabetes. 2004 Dec;53 Suppl 3:S16-21
15561905
J Am Coll Cardiol. 1996 Mar 15;27(4):847-52
8613613
Curr Atheroscler Rep. 2002 Mar;4(2):120-7
11822975
Eur Heart J. 2004 Jul;25(14):1242-8
15246643
Diabetes Res Clin Pract. 1995 Dec;30(3):211-21
8861461
Diabetes Care. 2000 Nov;23(11):1686-93
11092293
Diabetes Care. 1999 Feb;22(2):233-40
10333939
Diabetes Care. 1995 Dec;18(12):1534-43
8722048
Clin Sci (Lond). 1999 Jul;97(1):5-17
10369789
J Am Coll Cardiol. 1996 Aug;28(2):296-304
8800101
Crit Care Clin. 2001 Jan;17(1):75-106
11219236
J Clin Endocrinol Metab. 2007 Oct;92(10):3885-9
17666483
Circulation. 1998 May 5;97(17):1695-701
9591763
CMAJ. 2009 Sep 15;181(6-7):357, E106-7
19752139
Eur J Appl Physiol. 2008 Nov;104(5):803-12
18661145
Diabetologia. 2008 Jun;51(6):952-5
18415073
Neuroepidemiology. 2009;33(4):344-9
19887841
Circulation. 1997 Apr 1;95(7):1783-90
9107164